CSPC OUYI PHARMACEUTICAL CO., LTD.
🇨🇳China
- Country
- 🇨🇳China
- Ownership
- Subsidiary
- Established
- 2001-03-29
- Employees
- -
- Market Cap
- -
- Website
- http://www.e-cspc.com
Bioequivalence Study of Irinotecan Liposome Injection in Chinese Advanced Pancreatic Cancer.
Phase 1
- Conditions
- Advanced Pancreatic Cancer
- Interventions
- First Posted Date
- 2020-07-22
- Last Posted Date
- 2020-07-22
- Lead Sponsor
- CSPC Ouyi Pharmaceutical Co., Ltd.
- Target Recruit Count
- 48
- Registration Number
- NCT04482257
- Locations
- 🇨🇳
Tianjin Cancer Hospital, Tianjin, Tianjin, China
© Copyright 2025. All Rights Reserved by MedPath